Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $50.56 | 1 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $50.56 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $50.56 | 1 | Genentech USA, Inc. ($50.56) |
All Payment Transactions
1 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/14/2017 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $50.56 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 255 | 422 | $55,370 | $11,294 |
| 2022 | 6 | 285 | 491 | $62,625 | $15,162 |
| 2021 | 7 | 329 | 582 | $71,135 | $17,075 |
| 2020 | 6 | 273 | 440 | $52,450 | $12,519 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 65 | $14,230 | $3,964 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 80 | $11,500 | $3,385 | 29.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 54 | 69 | $15,180 | $2,596 | 17.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 45 | 54 | $12,150 | $1,127 | 9.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 41 | 154 | $2,310 | $224.03 | 9.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 111 | $22,295 | $7,726 | 34.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 57 | 77 | $16,555 | $3,026 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 59 | $7,755 | $2,657 | 34.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 44 | 52 | $11,440 | $1,141 | 10.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 12 | 20 | $2,000 | $347.29 | 17.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 43 | 172 | $2,580 | $265.00 | 10.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 74 | 105 | $20,475 | $7,080 | 34.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 82 | $10,660 | $4,111 | 38.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 74 | 98 | $20,580 | $3,682 | 17.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 38 | 49 | $10,780 | $1,010 | 9.4% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 16 | 34 | $3,230 | $554.72 | 17.2% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 11 | 11 | $2,365 | $325.10 | 13.7% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 53 | 203 | $3,045 | $313.00 | 10.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 103 | 132 | $25,740 | $7,514 | 29.2% |
| 17000 | Destruction of skin growth | Office | 2020 | 58 | 70 | $14,000 | $2,634 | 18.8% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 38 | 44 | $5,940 | $952.35 | 16.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 20 | $2,600 | $728.99 | 28.0% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2020 | 15 | 24 | $1,920 | $445.39 | 23.2% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 43 | 150 | $2,250 | $244.16 | 10.9% |
About Dr. David Lambert, MD
Dr. David Lambert, MD is a MOHS-Micrographic Surgery healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902815491.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Lambert, MD has received a total of $50.56 in payments from pharmaceutical and medical device companies, with $50.56 received in 2017. These payments were reported across 1 transactions from 1 company. The most common payment nature is "Food and Beverage" ($50.56).
As a Medicare-enrolled provider, Lambert has provided services to 1,142 Medicare beneficiaries, totaling 1,935 services with total Medicare billing of $56,051. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Columbus, OH
- Active Since 08/05/2006
- Last Updated 02/22/2021
- Taxonomy Code 207ND0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902815491
Products in Payments
- Erivedge (Biological) $50.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.